SOM BIOTECH Logo (WIPO, 07/20/2022)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark SOM BIOTECH was filed as Figurative mark on 07/20/2022 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Colours #Series of letters presenting different forms of writing #Three predominant colours
| Trademark form | Figurative mark |
| File reference | 1696738 |
| Register number | 018650684 |
| Countries | 
|
| Base trademark |
No. 018650684,
June 14, 2022
|
| Application date | July 20, 2022 |
| Expiration date | July 20, 2032 |
Trademark owner
Baldiri Reixac, 4
E-08028 Barcelona
ES
E-08028 Barcelona
ES
Trademark representatives
Avenida de Burgos, 16D,
4ª planta Edificio Euromor
ES
goods and services
05
Pharmaceuticals; pharmaceutical drugs; medicine;
pharmaceutical preparations for veterinary use;
pharmaceutical preparations for the prevention of disorders
of the nervous system; pharmaceutical preparations for the
prevention of diseases of the nervous system; pharmaceutical
preparations for the treatment of central nervous system
[CNS] diseases; pharmaceutical preparations for treating
metabolic disorders; chemical preparations for medical
purposes; chemical preparations for pharmaceutical purposes;
pharmaceutical agents affecting metabolism; pharmaceutical
preparations for treating malignant tumors; pharmaceutical
preparations for activating cellular function; medicines for
the treatment of cardiovascular and cerebrovascular
diseases; pharmaceutical preparations for the treatment of
Parkinson's disease; pharmaceutical preparations for the
prevention of disorders of the respiratory system;
pharmaceutical preparations for the prevention of diseases
of the respiratory system; pharmaceutical preparations for
the treatment of rare diseases; pharmaceuticals, for use in
the following fields: treatment of hereditary diseases;
pharmaceutical preparations for the treatment of
gastro-intestinal disorders; pharmaceutical products for the
treatment of infectious diseases; pharmaceuticals, for use
in the following fields: treatment of movement disorders;
pharmaceutical preparations for use in oncology;
pharmaceuticals for the treatment of immune system disease;
pharmaceuticals, for use in the following fields: treatment
of skeletal muscular diseases; pharmaceuticals, for use in
the following fields: treatment of hormone disorders;
pharmaceuticals, for use in the following fields: treatment
of skin diseases; pharmaceutical preparations for use in
ophthalmology; pharmaceuticals, for use in the following
fields: treatment of gynaecological diseases;
pharmaceuticals, for use in the following fields: treatment
of haematological diseases; pharmaceuticals, for use in the
following fields: treatment of paediatric diseases; drug
delivery agents; drug detoxifying agents; central nervous
system stimulants; respiratory stimulants; capsules for
medicines; cardiovascular drugs used in treating congestive
heart failure (CHF); preparations for detecting genetic
predispositions for medical purposes; reagents for use in
medical genetic testing; clinical medical reagents; cells
for medical use; tumor suppressing agents; tumour antigens;
biopharmaceuticals for the treatment of cancer
42
Clinical research; biological research; chemical
technological research; scientific research; biomedical
research; research services in the fields of computation
chemistry; medical and pharmacological research services;
pharmaceutical research and development; research and
development of vaccines and medicines; research relating to
molecular sciences; research relating to biotechnology;
genetic research; research and development in the field of
microorganisms and cells; stem cell research; research in
the field of artificial intelligence technology; research in
relation to the following fields: artificial intelligence
technology; pharmaceutical drug development services;
development of pharmaceutical preparations and medicines;
drug discovery services; implementation of preclinical
trials; clinical trials; biotechnology testing; providing
information about the results of clinical trials for
pharmaceutical products; consultancy pertaining to
pharmacology; consultancy relating to research in the field
of pharmacogenetics; consultancy relating to pharmaceutical
research and development; chemistry consultation;
consultancy relating to biotechnology; information on the
subject of scientific research in the field of biochemistry
and biotechnology; analysis in the field of molecular
biology; laboratory analysis in the field of chemistry;
design and development of medical technology; information
technology services for the pharmaceutical and healthcare
industries; design and development of computer software for
use with medical technology; design and development in
relation to the following fields: artificial intelligence
technology; drug repositioning research; drug combination
research
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 5, 2023 | 2023/32 Gaz | US | Rejection |
| April 24, 2023 | 2023/17 Gaz | GB | Rejection |
| July 20, 2022 | 2022/44 Gaz | EM | Registration |
ID: 141696738